Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-11-18
1989-09-05
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548542, C07D207273, A61K 3140
Patent
active
048639532
ABSTRACT:
The present invention provides R(+)-3-amino-1-hydroxypyrrolidin-2-one of formula I: ##STR1## or pharmaceutically acceptable acid addition salt thereof, which compound is useful as an anticonvulsant agent and in the treatment and/or prevention of neurodegenerative disorders.
REFERENCES:
Evans et al., Brain Research, 1978, 148, 536-542.
Barlos et al [C.A., 110(5):39341b] Liebigs Ann. Chem. (12) 1127-33 (1988).
Olverman [CA 109(19):163649b] Neuroscience (Oxford), 26 (1) 17-31 1988.
Foster et al [C.A., 96(17) 136522m]Br. J. Pharm., 74(3) 723-9 (1981).
Dimoto et al [CA 95(7):57583h] J. Biol. Chem., 256(10), 5134-43 (1981).
Leeson Paul D.
Williams Brian J.
DiPrima Joseph F.
Merck & Co. , Inc.
Nicholson William H.
Springer David B.
LandOfFree
[3R]-3-amino-1-hydroxy pyrrolidin-2-one and its use as a neuropr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with [3R]-3-amino-1-hydroxy pyrrolidin-2-one and its use as a neuropr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and [3R]-3-amino-1-hydroxy pyrrolidin-2-one and its use as a neuropr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-243830